Uniphar’s acquisition of Irish-headquartered pharmacy solutions business NaviCorp is to be investigated by the Competition and Consumer Protection Commission .
The deals were expected to deliver a return on capital employed to the group in line with Uniphar’s target rate of 12-15 per cent within three years.
IrishTimes So what if the final incarnation refuses to deal with the government on pharmaceutical pricing?
United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: businessposthq - 🏆 8. / 71 Read more »
Source: IrishTimesBiz - 🏆 6. / 77 Read more »